ClinicalTrials.gg
CompletedNCT01210924CN-PARTUpdated Mar 30, 2018

Chinese Network of Pediatric Antiretroviral Therapy

An observational study in Acquired Immunodeficiency Syndrome, sponsored by National Center for AIDS/STD Control and Prevention, China CDC. Completed at 1 site in China. Open to participants aged Up to 15 Years. Per ClinicalTrials.gov, last updated 2018-03-30.

Sponsored by National Center for AIDS/STD Control and Prevention, China CDC · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
Up to 15 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 87 studies in Acquired Immunodeficiency Syndrome with a site in China — 21 open to participants now, 24 under way, 1 of them phase 3. Acquired Immunodeficiency Syndrome · China.

Enrollment
8th of 18
400 · median 400
Started
2010
the only one that year
Observational
19 of 87
10 open now
Registered
10th of 87
by date
Lead sponsor
6 of 87
National Center for AIDS/STD Control and Prevention, China CDC

Among the 87 studies in Acquired Immunodeficiency Syndrome with a site in China, this one is the 8th largest by enrollment of the 18 observational ones that give a count, is the only one that started in 2010, is one of 19 observational ones, and was the 10th registered.

Acquired Immunodeficiency Syndrome

3,039 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 308 are open to participants now.

Browse Acquired Immunodeficiency Syndrome studies →

Open to participants now

21 of the 87 studies in Acquired Immunodeficiency Syndrome with a site in China are open now. Recruiting first, the newest first:

16 more — sign in →

All 21 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 197 Acquired Immunodeficiency Syndrome studies recruiting now, 117 (59%) set no upper age limit and 67 (34%) stop at 75 or younger; 43 take children under 18; 68 take healthy volunteers.

This study: Up to 15 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 87 studies in Acquired Immunodeficiency Syndrome with a site in China, or all of them as a file.
02

Study summary

This is an observational cohort in pediatric HIV patients in China. Children who receive antiretroviral drugs will be recruited in this study. The main objectives are as follows: 1. To establish simpler and smarter pediatric antiretroviral therapy in China including both first-line and second-line regimens. 2. To study the nature, characteristics and mechanisms of immunoreconstitution in HIV-infected children using the data and samples from the pediatric antiretroviral therapy cohort. 3. To establish a basic science and clinical research network based on the pediatric antiretroviral cohort.

03

Conditions studied

  • Acquired Immunodeficiency Syndrome

Keywords

  • children
  • Acquired Immunodeficiency Syndrome
  • antiretroviral therapy
  • China
  • Mortality
04

Who can participate

Ages eligible
Up to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pediatric HIV-infected patients receiving triple antiretroviral drugs

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • clinical diagnosis of infection
  • receiving triple antiretroviral drugs

Exclusion criteria

Exclusion Criteria:

  • clinical status not stable
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • Pediatric ART patients
06

What researchers measure

Primary outcomes

  1. The immunology and virologic outcomes

    Time frame: 2016

07

Study locations

1 site
  • National Center for AIDS/STD Control and Prevention, China Center for Disease Control and Prevention
    Beijing, 102206, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2010, a primary completion of Dec 2015 and a completion of Dec 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2010
First posted
Sep 29, 2010
Start
Apr 2010
Primary completionActual
Dec 2015
CompletionActual
Dec 2015
Last update
Mar 30, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 30, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01210924
Lead sponsor
National Center for AIDS/STD Control and Prevention, China CDC
Responsible party
Sponsor
First posted
Sep 29, 2010
Start date
Apr 2010
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Mar 30, 2018

Study contacts

Fujie Zhang, MD
principal investigator · National Center for AIDS/STD control and prevention

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion